期刊文献+

胃癌患者免疫功能状态研究 被引量:5

Analysis of the immunologic function in patients with gastric cancer
暂未订购
导出
摘要 目的:探讨胃癌患者外周血T淋巴细胞亚群(CD3、CD4和CD8)和血清白细胞介素-12(IL-12)、可溶性白细胞介素-2受体(sIL-2R)水平的变化及其与胃癌临床病理的关系。方法:应用流式细胞术和酶联免疫吸附试验检测80例胃癌患者手术前外周血CD3、CD4、CD8和血清IL-12、sIL-2R的水平,并以30例健康体检者为对照组。结果:胃癌患者CD3+、CD4+、CD4+/CD8+均明显低于正常对照组(P<0.01);胃癌患者血清IL-12水平低于正常对照组(P<0.01),而血清sIL-2R水平高于正常对照组(P<0.01)。胃癌患者T淋巴细胞亚群及血清IL-12和sIL-2R的改变与胃癌组织病理学类型、细胞分化程度无关,而与浸润程度有关。CD4+/CD8+与血清IL-12和sIL-2R之间存在显著相关性(P<0.05)。结论:胃癌患者外周血CD3、CD4、CD8和血清IL-12和sIL-2R水平可作为研究胃癌的发生、发展和转移的重要免疫学指标。 Objective:To explore the association of T-lymphocyte subsets and serum IL-12/sIL-2R levels with the clinieopathological factors in patients with gastric cancer. Methods:T-lymphocyte subsets and serum IL-12/sIL-2R levels in 80 patients with gastric cancer and 30 healthy controls were detected by immunofluorescence and enzyme linked immunosorbent assay(ELISA). Results:The CD3 ^+ T ceils, CD4 ^+T ceils and CD4 ^+/CD8 ^+ratio in the blood samples from the gastric cancer group were obviously lower than those from the control group( P 〈 0.01 ) ;the IL-12 level in patients with gastric cancer was lower and the IL-2R level higher compared to that in the control( P 〈 0.05 ). This changes were related to the tumor depth but not the histological types or the cell differentiation of the tumor. There was a significant correlation between serum IL-12/sIL-2R levels and CD4^+/CD8^+ ratio(P 〈 0.05 ). Condusions: The T- lymphocyte subsets and serum IL-12/sIL-2R levels can be used as an important immunology index of the genesis, development and metastasis of the gastric cancer.
出处 《蚌埠医学院学报》 CAS 2009年第8期671-674,共4页 Journal of Bengbu Medical College
关键词 胃肿瘤 免疫 细胞 T淋巴细胞亚群 白细胞介素-12 可溶性白细胞介素-2受体 stomach neoplasms immunity, cellular T-lymphocyte subsets interleakin-12/soluble interleukin-2 receptor
  • 相关文献

参考文献13

  • 1陈蔚峰.肿瘤免疫学[M].第3版.北京:人民卫生出版社,2002:203-215.
  • 2Lissoni P, Barni S, Rovelli F, et al. The biological significance of soluble interleukin-2 receptor in solid tumor [ J ]. Eur J Cancer, 1990,26( 1 ) :33 - 36.
  • 3Papachristou DN, Shiu MH. Management by en bloc multiple organ resection of carcinoma of the stomach invading adjacent organs [J]. Surg Gynecol Obstet, 1981,152 (4) :483 - 487.
  • 4詹友庆,李威,孙晓卫,陈映波,徐立,陈功,关远祥,李元方,徐大志,孙献甫,张华政,林振文.胃癌外科治疗的远期疗效研究[J].中华外科杂志,2005,43(17):1109-1113. 被引量:82
  • 5詹友庆,孙晓卫,李威,陈映波,徐立,关远祥,李元方,徐大志.影响根治术后胃癌预后的多因素分析[J].癌症,2005,24(5):596-599. 被引量:63
  • 6Yasutomo K. The cellular and molecular mechanism of CD4/CD8 lineage commitment [ J ]. J Med Invest,2002,49 ( 1 - 2 ) : 1 - 6.
  • 7Chattopadhyay S, Chakraborty NG, Mukherji B. Regulatory T cells and tumor immunity[ J ]. Cancer Immunol Immunother, 2005,54 (12) :1153 -1161.
  • 8Jasnis MA, Eljtin AM, Oisgold-Dagti S. Regulation of tumor growth by soluble spleen factor: effect of tumor resection [ J ]. J Surg Oncol,1987,35 (2) :139 -145.
  • 9Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I . Definition according to profiles of lymphokine activities and secreted proteins [ J ]. J Immunol, 1986,136 (7) :2348 - 2357.
  • 10Romagnani S. Homan TH1 and TH2 subsets:doubt no more[ J]. Immunol Today, 1991,12 ( 8 ) :256 - 257.

二级参考文献25

  • 1林言箴,尹浩然,薛建元,朱寿柱,朱正纲,李树发,燕敏.胃癌外科治疗30年回顾[J].外科,1996,1(1):7-10. 被引量:14
  • 2邢福成,王殿昌.胃癌根治术预后临床病理因素分析[J].齐鲁肿瘤杂志,1997,4(2):121-123. 被引量:9
  • 3Yamamura Y, Nakajima T, Ohta K, et al. Determining prognostic factors for gastric cancer using the regression tree method [ J ]. Gastric Cancer, 2002,5 (4): 201-207.
  • 4徐光炜 张天泽 徐光炜.胃癌[M].张天泽,徐光炜.肿瘤学(中册)[C].天津:科学技术出版社,1993.1447.
  • 5Bozzetti F, Bonfanti G, Morabito A, et al. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection [J]. Surg Gynecol Obster,1986,162(3 ) :229-234.
  • 6Kang JH, Han JY, Hong YS, et al. Neoadjuvant chemotherapy in patients with locally advanced gastric cancer [C]. 3rd Int. Gastric Cancer Cong., Seoul, 1999:250.
  • 7Kim JP. Surgical results with immunochemotherapy [C]. In:Kim JP, Min JS, Mok YJ, eds. Proceeding of the 3rd International Gastric Cancer Congress, Seoul: Monduzzi Editore, 1999:3-9.
  • 8Popiela T. The role of chemoimmunotherapy in gastric cancer patients treatment: result from Polish Gastric Cancer Study [C]. 3rd Int. Gastric Cancer Cong., Seoul: Monduzzi Editore, 1999:23.
  • 9Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer [J]. Br J Surg, 1997,84(12): 1651-1664.
  • 10Maruyam K. Japanese staging system for gastric cancer [J].Scand J Gastroenterol, 1981,22 (Suppl 133): 22.

共引文献139

同被引文献21

引证文献5

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部